Where ALX Oncology Holdings Stands With Analysts
Portfolio Pulse from Benzinga Insights
Analysts have provided mostly bullish ratings for ALX Oncology Holdings (NASDAQ:ALXO) in the last quarter. According to 6 analysts offering 12-month price targets in the last 3 months, ALX Oncology Holdings has an average price target of $16.67, representing a 45.34% decrease from the previous average price target of $30.50.
September 07, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Analysts are mostly bullish on ALX Oncology Holdings, but the average price target has decreased by 45.34% to $16.67.
The bullish ratings from analysts indicate a positive outlook for ALX Oncology Holdings. However, the significant decrease in the average price target could suggest that analysts are adjusting their expectations downwards, which could potentially impact the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100